Tomosynthesis (TS) Versus Ultrasonography (US) in Women With Dense Breast
- Conditions
- Breast Cancer
- Interventions
- Device: 3D mammography (Tomosynthesis)Device: Ultrasound
- Registration Number
- NCT02066142
- Lead Sponsor
- University of Genova
- Brief Summary
Hypothesis The study aims to demonstrate at least equivalence, or non-significant difference between TS and US in women with dense breast screened negative at 2D Mammography.
If the equivalence between TS and US will be demonstrated, US may be substituted by TS with great benefits for the patients and for the healthcare resources.
Aims
1. Assess if TS may detect additional cancers in dense breast that approximate US detection capability but with less false positive findings than US.
2. If TS detects new cancers in dense breast similarly to US (approximate rate or marginally lower rate), evaluate the the true positive/false positive ratio.
3. Cost-analysis. In case of less false positives detected by TS, the true-positive / false positive trade-off might be strongly in favour of TS with a great potential of costs reduction.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- Female
- Target Recruitment
- 4000
- Asymptomatic subjects <50 years of age presenting for mammography, with the exception of those that, on previous mammograms are found to have breast density 1-2 according to the Breast Imaging Reporting and Data System (BIRADS D1-2). - Asymptomatic subjects ≥ 50 years of age who request mammography and have breast density BIRADS 3-4.
- No history of breast cancer - Written informed consent
- Pregnant and breast feeding women
- Unable to tolerate breast compression
- Breast implants
- Unable to understand or execute written informed consent
- Unable or unwilling to agree to follow-up during observation period
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Tomosynthesis 3D mammography (Tomosynthesis) Tomosynthesis will be compared to Ultrasound Ultrasound Ultrasound Ultrasound (sensitivity and specificity) will be compared to Tomosynthesis
- Primary Outcome Measures
Name Time Method 1) Sensitivity of TS up to 36 months We want to verify if TS may detect additional cancers in dense breast that approximate US detection capability but with less false positive findings than US.
- Secondary Outcome Measures
Name Time Method 2) Specificity of TS up to 36 months If TS detects new cancers in dense breast similarly to US (approximate rate or marginally lower rate), evaluate the the true positive/false positive ratio.
Trial Locations
- Locations (1)
UNIGE
🇮🇹Genova, Italy